Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine

Kanokudom, S; Assawakosri, S; Suntronwong, N; Auphimai, C; Nilyanimit, P; Vichaiwattana, P; Thongmee, T; Yorsaeng, R; Srimuan, D; Thatsanatorn, T; Klinfueng, S; Sudhinaraset, N; Wanlapakorn, N; Honsawek, S; Poovorawan, Y

Poovorawan, Y (通讯作者)，Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok 10330, Thailand.;Honsawek, S (通讯作者)，Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Fac Med,Thai Red Cross Soc, Osteoarthrit & Musculoskeleton Res Unit,Dept Bi, Bangkok 10330, Thailand.;Poovorawan, Y (通讯作者)，Royal Soc Thailand FRS T, Sanam Sueapa, Bangkok 10330, Thailand.

VACCINES, 2022; 10 (1):

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has become a severe healthcare problem worldwide since the first outbreak in late December 2019. Curr......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索